# Ethos Technologies Inc.: overview

LIFE · Nasdaq · CIK 1788451 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/life.md) · [Financials](/companies/life/financials.md) · [Filings](/companies/life/filings.md) · [Insiders](/companies/life/insiders.md)

Latest reported revenue: [$189.6m](/filings/0001193125-26-335209.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-335209).

## Last eight quarters

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $m | [94.9](/filings/0001193125-26-214620.md) | [88.8](/filings/0001193125-26-335209.md) | [193](/filings/0001193125-26-214620.md) | [190](/filings/0001193125-26-335209.md) |
| Gross margin | % | not reported | not reported | not reported | not reported |
| Operating margin | % | [13.2%](/filings/0001193125-26-214620.md) | [21.2%](/filings/0001193125-26-335209.md) | [(84.6%)](/filings/0001193125-26-214620.md) | [9.6%](/filings/0001193125-26-335209.md) |
| Net margin | % | [12.9%](/filings/0001193125-26-335209.md) | [20.8%](/filings/0001193125-26-335209.md) | [(86.2%)](/filings/0001193125-26-335209.md) | [10.3%](/filings/0001193125-26-335209.md) |
| Diluted EPS | $ per share | [0.21](/filings/0001193125-26-214620.md) | [0.31](/filings/0001193125-26-335209.md) | [(3.57)](/filings/0001193125-26-214620.md) | [0.30](/filings/0001193125-26-335209.md) |
| Free cash flow | $m | [10.5](/filings/0001193125-26-214620.md) | [12.9 d](/filings/0001193125-26-335209.md) | [30.9](/filings/0001193125-26-214620.md) | [35.3 d](/filings/0001193125-26-335209.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: |
| Revenue | $m | [255](/filings/0001193125-26-108887.md) | [388](/filings/0001193125-26-108887.md) |
| Gross margin | % | not reported | not reported |
| Operating margin | % | [19.1%](/filings/0001193125-26-108887.md) | [18.8%](/filings/0001193125-26-108887.md) |
| Net margin | % | [19.2%](/filings/0001193125-26-108887.md) | [18.4%](/filings/0001193125-26-108887.md) |
| Diluted EPS | $ per share | [0.85](/filings/0001193125-26-108887.md) | [1.22](/filings/0001193125-26-108887.md) |
| Free cash flow | $m | [(11.7)](/filings/0001193125-26-108887.md) | [34.7](/filings/0001193125-26-108887.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/life/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Alphabet Inc.](/funds/1652044.md) | 2026-06-30 | $65.7m | 3,622,604 |  | Reduced −147,552 |
| [SOFTBANK GROUP CORP.](/funds/1065521.md) | 2026-06-30 | $56.8m | 3,128,902 |  | Unchanged |
| [Divisadero Street Capital Management, LP](/funds/1901865.md) | 2026-06-30 | $29.7m | 1,635,921 |  | New +1,635,921 |
| [Capital World Investors](/funds/1422849.md) | 2026-06-30 | $23.9m | 1,315,789 |  | Unchanged |
| [GLADE BROOK CAPITAL PARTNERS LLC](/funds/1529872.md) | 2026-06-30 | $15.6m | 857,862 |  | Reduced −285,952 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $8.8m | 487,570 |  | Added +1,313 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $7.6m | 417,412 |  | Reduced −46,441 |
| [CANNELL CAPITAL LLC](/funds/1058854.md) | 2026-06-30 | $7.4m | 408,496 |  | Reduced −43,841 |
| [HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND](/funds/1535845.md) | 2026-06-30 | $6.3m | 350,000 |  | Reduced −350,000 |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $6.2m | 342,500 |  | Added +262,500 |

## Recent filings

[All 123 filings](/companies/life/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-09 | 20:05 ET | [8-K](/filings/0001193125-26-419073.md) | 8.01 Other events | 0001193125-26-419073 |
| 2026-09-16 | 12:58 ET | [8-K](/filings/0001193125-26-392523.md) | 7.01 Regulation FD disclosure | 0001193125-26-392523 |
| 2026-08-05 | 20:22 ET | [10-Q](/filings/0001193125-26-335209.md) | Quarterly report, period 2026-06-30 | 0001193125-26-335209 |
| 2026-08-03 | 20:07 ET | [8-K](/filings/0001193125-26-330556.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-330556 |
| 2026-05-08 | 20:08 ET | [10-Q](/filings/0001193125-26-214620.md) | Quarterly report, period 2026-03-31 | 0001193125-26-214620 |
| 2026-05-06 | 20:06 ET | [8-K](/filings/0001193125-26-208936.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-208936 |
| 2026-03-17 | 00:04 ET | [10-K](/filings/0001193125-26-108887.md) | Annual report, period 2025-12-31 | 0001193125-26-108887 |
| 2026-02-25 | 21:29 ET | [8-K](/filings/0001193125-26-071749.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-071749 |
| 2026-02-02 | 12:02 ET | [8-K](/filings/0001193125-26-032634.md) | 1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-032634 |
| 2026-01-20 | 11:57 ET | [S-1/A](/filings/0001193125-26-015943.md) | Registration statement, amended | 0001193125-26-015943 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-108887.md), filed Mar 17, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/e86bcefb-3510-4174-84f8-d8e4c65d49a0)

## About the filer

- CIK: 1788451
- Tickers: LIFE
- Exchange: Nasdaq
- SIC code: 6411 Insurance Agents, Brokers & Service
- State of incorporation: DE
- Filer category: <br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.